Developing a new drug delivery technologies and utilizing them in product development is critical for pharmaceutical industries to isurvive, regardless of their size. As a drug nears the end of its patent life, it is common for pharmaceutical manufacturers to develop a given drug entity in a new and improved dosage form. A new dosage form allows a manufacturer to extend market exclusivity, unique product differentiation, value-added product line extension, and extend patent protection, while offering its patient population a more convenient dosage form. This leads to increased revenue, while also targeting under-served and under-treated patient ipopulations. Marketers build a better brand and company image when they offer a unique easier-to-take form that satisfies the need of an underserved patient population.
| Autorius: | Gulfisha Shaikh, Raksha Goswami, Apoorva Tiwari Deepak Kumawat, |
| Leidėjas: | LAP LAMBERT Academic Publishing |
| Išleidimo metai: | 2021 |
| Knygos puslapių skaičius: | 68 |
| ISBN-10: | 6203862150 |
| ISBN-13: | 9786203862157 |
| Formatas: | Knyga minkštu viršeliu |
| Kalba: | Anglų |
| Žanras: | Educational systems and structures |
Parašykite atsiliepimą apie „Textbook on Development and Evaluation of Liquid Dosage Form“
